Macquarie Group
GNMX

Macquarie Group’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History

Macquarie Group’s Portfolio GNMX Stock Details GNMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-7,058
Closed -$8K – 2496
2017
Q4 		$8K Buy
+7,058
New +$8K ﹤0.01% 2323